a·lac·ri·ty [uh-lak-ri-tee] cheerful readiness, promptness, or willingness
Europe: London BioScience Innovation Centre 2 Royal College Street London NW1 0NH
USA: Cambridge Innovation Center 1 Broadway, 14th Floor Kendall Square, Cambridge MA 02142

changing the face
of life sciences consulting

 

Trusted people

Martin Reeves

Martin Reeves has more than 32 years of experience in the pharmaceutical industry in both Europe and in the U.S., with the last five years as head of business development at Cephalon/Teva…

Read more »

Case studies

510(k) consulting for respiratory medical device

Alacrita's 501(k) regulatory affairs specialist supported a UK medical device company secure 510(k) clearance from FDA for a respiratory measurement device

Read more »

Antibodies

Alacrita has substantial expertise in antibody discovery, development and commercialisation. We have helped a number of clients assess antibody opportunities, including target and technology assessment, strategic valuation and biosimilar market positioning...

Read more »

Business Development and Partnering Support

Alacrita provides opportunity assessment, valuation and deal structure support to both in-licensors and out-licensors. We work alongside in-house licensing and business development professionals providing real world experience and data upon which to base critical transaction decisions...

Read more »

Cancer clinical development strategy

Alacrita's expert medical team provides medical advisory services including clinical development strategy and operational Chief Medical Officer support...

Read more »

Cancer immunotherapy consulting

Alacrita has advised a number of cancer immunotherapy companies on a diverse range of projects. Examples include valuation models to support partnering discussions for a highly potent autologous cell-based cancer immunotherapy, through to clinical strategy advice for a company developing a peptide-based approach.

Read more »